BioSpace News Archive

Curebase, a company committed to democratizing access to clinical studies, today announced that Luminostics utilized the company’s virtual site solution to power clinical studies for its Clip COVID Rapid Antigen Test, which was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on December 7, 2020.

October and November 2020 trading performance has been strong. It is therefore now confirmed that Eurofins will significantly exceed its financial objectives for 2020

Targovax ASA invites investors, analysts and media to a Capital Markets Day on Thursday 18 February 2021

BetterLife Pharma Inc., an emerging biotech focused on the development and commercialization of cutting edge treatments, announced the value proposition of its acquisition of Transcend Biodynamics, LLC’s manufacturing patent “Process of synthesizing 2-Bromo-LSD.”

France-based biotechnology company AlgoTherapeutix, the developer of an innovative topical treatment for chemotherapy-induced peripheral neuropathy, announced it has received approval from the ethics committee and the regulatory authority in the Czech Republic to initiate a Phase 1 clinical trial with ATX01.

Cyxone, a clinical stage biotech company developing first-in-class drugs for diseases of the immune system, announced that the company has filed an Investigational New Drug application with the US Food and Drug Administration pertaining to its drug candidate Rabeximod.

Alume Biosciences, Inc. announced that it has been awarded a $2.5M Phase II Small Business Innovation Research grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health.

Electromedical Technologies, Inc., a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce that its annual product special offer is generating solid demand and interest, which is typical of this holiday season cyber campaign.

Immuron’s Hyper-immune Bovine Colostrum, used to manufacture Travelan® and Protectyn®, demonstrated antiviral activity against the SARS-CoV-2/COVID-19 virus in laboratory studies.

Baylis Medical announced the Canadian launch of its EPstar Electrophysiology Catheters.